Global Glycopyrronium Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Glycopyrronium Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Glycopyrronium is used with other drugs to treat a certain type of stomach/intestinal ulcer (peptic ulcer). This medication may help relieve stomach/abdominal pain. However, it has not been shown to be effective in healing these ulcers, preventing them from returning, or preventing other problems caused by ulcers. Glycopyrronium works by decreasing the amount of acid in the stomach. It also slows the natural movements of the gut and relaxes the muscles in the stomach/intestines. Glycopyrronium belongs to a class of drugs known as anticholinergics.
Glycopyrronium report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Glycopyrronium market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Glycopyrronium industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Glycopyrronium key manufacturers include Accord Healthcare, AstraZeneca, Merz Pharmaceuticals, Carwin Pharma, Sunovion Pharmaceuticals, Shionogi Inc, Novartis AG, Proveca Limited and Martindale Pharma, etc. Accord Healthcare, AstraZeneca, Merz Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Glycopyrronium can be divided into Injection, Oral Solution, Tablet and Capsule, etc. Injection is the mainstream product in the market, accounting for % sales share globally in 2022.
Glycopyrronium is widely used in various fields, such as Hospital and Clinic, etc. Hospital provides greatest supports to the Glycopyrronium industry development. In 2022, global % sales of Glycopyrronium went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Glycopyrronium market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Accord Healthcare
AstraZeneca
Merz Pharmaceuticals
Carwin Pharma
Sunovion Pharmaceuticals
Shionogi Inc
Novartis AG
Proveca Limited
Martindale Pharma
Meitheal Pharmaceuticals
Segment by Type
Injection
Oral Solution
Tablet
Capsule
Hospital
Clinic
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Glycopyrronium market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Glycopyrronium, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Glycopyrronium industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Glycopyrronium in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Glycopyrronium introduction, etc. Glycopyrronium Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Glycopyrronium market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Glycopyrronium report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Glycopyrronium market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Glycopyrronium industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Glycopyrronium key manufacturers include Accord Healthcare, AstraZeneca, Merz Pharmaceuticals, Carwin Pharma, Sunovion Pharmaceuticals, Shionogi Inc, Novartis AG, Proveca Limited and Martindale Pharma, etc. Accord Healthcare, AstraZeneca, Merz Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Glycopyrronium can be divided into Injection, Oral Solution, Tablet and Capsule, etc. Injection is the mainstream product in the market, accounting for % sales share globally in 2022.
Glycopyrronium is widely used in various fields, such as Hospital and Clinic, etc. Hospital provides greatest supports to the Glycopyrronium industry development. In 2022, global % sales of Glycopyrronium went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Glycopyrronium market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Accord Healthcare
AstraZeneca
Merz Pharmaceuticals
Carwin Pharma
Sunovion Pharmaceuticals
Shionogi Inc
Novartis AG
Proveca Limited
Martindale Pharma
Meitheal Pharmaceuticals
Segment by Type
Injection
Oral Solution
Tablet
Capsule
Segment by Application
Hospital
Clinic
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Glycopyrronium market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Glycopyrronium, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Glycopyrronium industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Glycopyrronium in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Glycopyrronium introduction, etc. Glycopyrronium Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Glycopyrronium market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices